Last public consultation:
- Dinotefuran PT 18
- Medetomidine (RS)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole (Racemic) PT 21
- N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium borate (Polymeric betaine) PT 8
Deadline for communication of information: 04/01/2024
- 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (Prallethrin) PT18
Deadline for communication of information: 22/01/2024
More information and commenting on ECHA website: